City Hospital of Saint Martyr Elizabeth

Saint Petersburg 195257

0 studies enrolling now · 3 studies all time

What they study most

Crohn's Disease, Diabetes Mellitus, Type 2, Type 2 Diabetes Mellitus

Studies at this site

• A Study of Mirikizumab (LY3074828) in Participants With Active Crohn's Disease — Completed
• A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular Risk — Completed
• A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes — Completed